Neonatal Isolation Increases the Susceptibility to Learned Helplessness through the Aberrant Neuronal Activity in the Ventral Pallidum of Rats.

Associative and implicit learning Learned helplessness Neonatal isolation Neuronal activity Ventral pallidum

Journal

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
ISSN: 1738-1088
Titre abrégé: Clin Psychopharmacol Neurosci
Pays: Korea (South)
ID NLM: 101207332

Informations de publication

Date de publication:
31 May 2024
Historique:
received: 14 10 2023
revised: 26 12 2023
accepted: 27 12 2023
medline: 17 4 2024
pubmed: 17 4 2024
entrez: 16 4 2024
Statut: ppublish

Résumé

: Environmental deprivation, a type of childhood maltreatment, has been reported to constrain the cognitive developmental processes such as associative learning and implicit learning, which may lead to functional and morphological changes in the ventral pallidum (VP) and pessimism, a well-known cognitive feature of major depression. We examined whether neonatal isolation (NI) could influence the incidence of learned helplessness (LH) in a rat model mimicking the pessimism, and the number of vesicular glutamate transporter 2 (VGLUT2)-expressing VP cells and Penk-expressing VP cells. : The number of escape failures from foot-shocks in the LH test was measured to examine stress-induced depression-like behavior in rats. The number of VGLUT2-expressing VP cells and Penk-expressing VP cells was measured by immunohistochemistry. : In NI rats compared with Sham rats, the incidence of LH in adulthood was increased and VGLUT2-expressing VP cells but not Penk-expressing VP cells in adulthood were decreased. VGLUT2-expressing VP cells were decreased only in the LH group of NI rats and significantly correlated with the escape latency in the LH test. : These findings suggest that the aberrant VP neuronal activity due to environmental deprivation early in life leads to pessimistic associative and implicit learning. Modulating VP neuronal activity could be a novel therapeutic and preventive strategy for the patients with this specific pathophysiology.

Identifiants

pubmed: 38627082
pii: cpn.23.1140
doi: 10.9758/cpn.23.1140
pmc: PMC11024705
doi:

Types de publication

Journal Article

Langues

eng

Pagination

354-363

Références

Trends Neurosci. 1989 Oct;12(10):366-75
pubmed: 2479133
Behav Brain Res. 2016 Mar 1;300:175-83
pubmed: 26615907
Behav Res Ther. 2006 Jun;44(6):861-82
pubmed: 16126162
Hippocampus. 1999;9(6):651-8
pubmed: 10641758
J Neurophysiol. 2006 Nov;96(5):2399-409
pubmed: 16885520
Nat Commun. 2018 Feb 27;9(1):849
pubmed: 29487284
Lancet Psychiatry. 2015 Jul;2(7):625-34
pubmed: 26303560
Biol Psychiatry. 2017 Oct 1;82(7):462-471
pubmed: 28392082
Annu Rev Neurosci. 2008;31:359-87
pubmed: 18558860
Pharmacol Biochem Behav. 2006 Jan;83(1):28-34
pubmed: 16458953
Am J Psychiatry. 2001 Nov;158(11):1878-83
pubmed: 11691695
Pharmacol Rep. 2013;65(6):1451-61
pubmed: 24552992
Am J Psychiatry. 2005 Aug;162(8):1403-13
pubmed: 16055761
J Comp Neurol. 2013 Feb 15;521(3):558-88
pubmed: 22806483
Behav Brain Res. 2008 Jan 10;186(1):91-7
pubmed: 17854917
Prog Neurobiol. 2015 Jul;130:29-70
pubmed: 25857550
Arch Gen Psychiatry. 2007 Jan;64(1):49-56
pubmed: 17199054
Eur J Neurosci. 2006 Mar;23(6):1596-604
pubmed: 16553623
Front Psychiatry. 2011 Jun 28;2:39
pubmed: 21747771
Ann N Y Acad Sci. 2006 Jul;1071:313-23
pubmed: 16891580
Stress. 2015;18(4):427-34
pubmed: 26037264
Front Psychol. 2019 Aug 02;10:1668
pubmed: 31428006
Biol Psychiatry. 2021 Aug 1;90(3):182-193
pubmed: 33952400
Neuron. 2016 Oct 5;92(1):214-226
pubmed: 27667004
Front Cell Neurosci. 2014 Sep 22;8:294
pubmed: 25294985
J Child Psychol Psychiatry. 2017 Apr;58(4):338-357
pubmed: 28295339
Dev Psychopathol. 2015 May;27(2):493-505
pubmed: 25997767
Trends Neurosci. 1990 Jul;13(7):266-71
pubmed: 1695401
Neuroscience. 2014 Dec 12;282:49-59
pubmed: 24769227
Neuroscience. 2008 Mar 18;152(2):321-30
pubmed: 18272291
Horm Behav. 2009 Jun;56(1):112-20
pubmed: 19341740
Cell Tissue Res. 2013 Oct;354(1):171-8
pubmed: 23760889
Am J Psychiatry. 2006 May;163(5):786-8
pubmed: 16648316
Pharmacol Biochem Behav. 1986 Aug;25(2):415-21
pubmed: 2945212
Nat Rev Neurosci. 2016 Sep 19;17(10):652-66
pubmed: 27640984
J Exp Psychol. 1967 May;74(1):1-9
pubmed: 6032570
Am J Psychiatry. 2009 Jul;166(7):777-85
pubmed: 19487394
Eur J Neurosci. 2020 Jul;52(1):2466-2486
pubmed: 31631413
J Psychopharmacol. 1996 Jan;10(1):39-47
pubmed: 22302726
Am J Psychiatry. 2012 Feb;169(2):141-51
pubmed: 22420036
Psychol Rev. 2016 Jul;123(4):349-67
pubmed: 27337390
Psychiatry Clin Neurosci. 2019 Jun;73(6):289-301
pubmed: 30734985
Biol Psychiatry. 2018 Jun 15;83(12):1012-1023
pubmed: 29452828
Arch Gen Psychiatry. 2012 Nov;69(11):1151-60
pubmed: 23117636
J Neurosci. 1987 Apr;7(4):1022-30
pubmed: 2883265
Cereb Cortex. 2017 Apr 1;27(4):2528-2543
pubmed: 27114173
Neurochem Int. 2019 Jun;126:11-18
pubmed: 30797970
Brain Res. 2019 Jun 15;1713:62-69
pubmed: 30300634
Curr Biol. 2000 Jul 13;10(14):R509-11
pubmed: 10899013

Auteurs

Hironori Kobayashi (H)

Division of Graduate School of Biomedical and Health Sciences, Department of Psychiatry and Neuroscience, Hiroshima University, Hiroshima, Japan.

Manabu Fuchikami (M)

Division of Graduate School of Biomedical and Health Sciences, Department of Psychiatry and Neuroscience, Hiroshima University, Hiroshima, Japan.

Kenichi Oga (K)

Division of Graduate School of Biomedical and Health Sciences, Department of Psychiatry and Neuroscience, Hiroshima University, Hiroshima, Japan.

Tatsuhiro Miyagi (T)

Division of Graduate School of Biomedical and Health Sciences, Department of Psychiatry and Neuroscience, Hiroshima University, Hiroshima, Japan.

Sho Fujita (S)

Division of Graduate School of Biomedical and Health Sciences, Department of Psychiatry and Neuroscience, Hiroshima University, Hiroshima, Japan.

Satoshi Fujita (S)

Division of Graduate School of Biomedical and Health Sciences, Department of Psychiatry and Neuroscience, Hiroshima University, Hiroshima, Japan.

Satoshi Okada (S)

Division of Graduate School of Biomedical and Health Sciences, Department of Psychiatry and Neuroscience, Hiroshima University, Hiroshima, Japan.

Yasumasa Okamoto (Y)

Division of Graduate School of Biomedical and Health Sciences, Department of Psychiatry and Neuroscience, Hiroshima University, Hiroshima, Japan.

Shigeru Morinobu (S)

Department of Occupational Therapy, School of Health Science and Social Welfare, Kibi International University, Takahashi, Japan.

Classifications MeSH